Transcript Highlights:

• And then there's a formulary, which I was Representative Chasson.
• formulary that could be used for auto approval.
• And the formulary—Nevada's not costing them a dime because we give the formulary.
• Not the formulary. Okay.
• were not covered under the Texas formulary.

Summary: The House Labor and Industrial Relations Committee met on May 7, 2026, and first deferred several measures, including House Bill 460, Senate Bill 322, Senate Bill 32, Senate Bill 22, and House Bill 561. The committee then took up House Bill 819 by Chairman Cruz, which would replace Louisiana’s current workers’ compensation medical treatment schedule with the Official Disability Guidelines (ODG) by MCG as the primary guideline, while keeping the existing variance and appeal process. Cruz and MCG representative Troy Prevo argued that ODG is more comprehensive, updated more frequently, and used in many states, and said it could reduce delays, disability duration, and costs. Dr. Jason Picard, the state medical director, testified that Louisiana already uses ODG as a secondary reference in many cases because the state schedule lacks coverage for some body parts and treatments, and said the bill would not otherwise change the appeals process or care delivery. Committee members focused heavily on whether the bill would delay care or improve it. Several members questioned the private-company nature of ODG, the $400 annual subscription cost, and whether Louisiana doctors would be forced to rely on an out-of-state guideline. Rep. Glorioso and others raised concerns about preauthorization delays and proposed amendments to create tacit approval when treatment follows the schedule, require payment within 30 days, and make the carrier prove by clear and convincing evidence that care was not medically necessary to challenge it. Chairman Cruz said he was willing to work with those ideas, and the committee also discussed adding an on-ramp or legacy language so current patients would not be disrupted. Opposition testimony came from injured-worker advocates and representatives of medical and labor groups, including Joseph Jola St. and Robin Krumholt. They argued that Louisiana’s current guidelines are already working, that rates have fallen over time, and that the real problem is delay in approval rather than the content of the schedule. They said ODG is overly rigid, cost-driven, and can lead to denials that shift costs to workers, Medicaid, or private health insurance. They urged the committee to keep Louisiana’s existing system and instead adopt tacit approval under current law. The bill was still under discussion at the close of the transcript, with amendments being read and no final vote shown.

Transcript Highlights:

• have problems getting my albuterol every three months because they change the generic that's on the formulary

Bills: SB20, SB21, SB166, SB177, SB181, SB189, SM6

Keywords: prior authorization, pharmacy benefits manager, PBM, health insurer, prescription drugs, step therapy, formulary, auto-adjudication, electronic portal, appeals, medical necessity, serious mental illness, mental health, schizophrenia, bipolar disorder, major depression, substance use disorder, addiction treatment, cancer, autoimmune disorder

Transcript Highlights:

• And these Medicare Advantage plans can also change their formulary, their drug formulary, which is something
• we've talked about a lot on this floor, how unfair it is when you're on a drug and suddenly the formulary
• ,<00:17:05.120> their<00:17:05.439> drug<00:17:05.760> formulary,<00:17:06.480><
• c> which formulary, their drug formulary, which formulary, their drug formulary, which is<00:17:06.880
• on a drug and suddenly the formulary on a drug and suddenly the formulary gets<00:17:13.120>

Keywords: 1183, house

Transcript Highlights:

• And that is a that is a list formulary. And that is a that is a list formulary.
• If that drug is not listed in the formulary, then it's not u it's in the formulary, then it's not u it's
• , the pharmaceutical industry formulary, the pharmaceutical industry formulary, the pharmaceutical industry
• or they give rebates back to formulary or they give rebates back to formulary or they give rebates back
• . formulary. formulary.

Bills: SCR 13, SCR 24, SB 1, SB 12, SB 15, SB 17, SB 24, SB 57, SB 65, SB 213, SB 371, SB 372, SB 378, SB 379, SB 388, SB 400, SB 402, SB 427, SB 495, SB 499, SB 502, SB 509, SB 535, SB 583, SB 610, SB 621, SB 650, SB 706, SB 740, SB 840, SB 854, SB 856, SB 875, SB 893, SB 918, SB 925, SB 974, SB 995, SB 1006, SB 1018, SB 1025, SB 1061, SB 1073, SB 1106, SB 1121, SB 1194, SB 1252, SB 1253, SB 1268, SB 1300, SB 1343, SB 1362, SB 1447, SJR 36, SJR 12, SJR 57, SCR 25, SCR 22, SCR 12, SCR 24, SCR 8, SB 565, SB 372, SB 765, SB 62, SB 666, SB 707, SB 888, SB 687, SB 847, SB 1248, SB 740, SB 14, SB 1006, SB 504, SB 925, SB 1121, SB 995, SB 857, SB 305, SB 296, SB 284, SB 815, SB 1379, SB 1300, SB 1497, SB 1499, SB 1498, SB 1061, SB 65, SB 241, SB 304, SB 402, SB 499, SB 621, SB 974, SB 1023, SB 1024, SB 1025, SB 1106, SB 686, SB 112, SB 371, SB 204, SB 400, SB 609, SB 1447, SB 670, SB 502, SB 427, SB 850, SB 854, SB 413, SB 1555, SB 1362, SB 1346, SB 1033, SB 1220, SB 1073, SB 810, SB 987, SB 1539, SB 893, SB 447, SB 875, SB 406, SB 509, SB 985, SB 965, SB 1119, SB 1505, SB 24, SB 57, SB 1194, SB 1253, SB 1215, SB 1532, SB 1268, SB 1302, SB 856, SB 650, SB 583, SB 673, SB 840, SB 213, SB 681, SB 1172, SB 1252, SB 378, SB 610, SB 918, SB 1343, SB 608, SB 487, SB 955, SB 957, SB 988, SB 990, SB 1019, SB 1021, SB 1120, SB 251, SB 958, SB 535, SB 761, SB 1, SB 541, SB 315, SB 379, SB 1018, SB 1737, SB 266, SB 1415, SB 57, SB 499, SB 974, SB 1025, SB 1061, SB 1268, SR 302, SR 303, SR 304, SR 305, SB 30, SB 1333, SB 1666, SB 30, SB 1333, SB 1666

Keywords: water rights, treaty compliance, Rio Grande, agriculture, drought, international water, Texas water supply, Texas, Israel, trade, investment, partnership, economic ties, technological innovation, bilateral relations, appropriations, budget, state funding, education, healthcare

Transcript Highlights:

• This will be the March and April Employee Benefits Division formulary recommendations.
• lower-cost options that we're restructuring to make sure that we have the lower-cost preferred on our formulary
• The formulary is an active, living, breathing document.
• So I will say when we have switched to a new pharmacy benefit manager, yes, there was a overall formulary
• The formulary is an active living, breathing document.

Summary: The State Insurance Programs Oversight Subcommittee met on June 17 and reviewed a series of Employee Benefits Division and Office of Property Risk items. Grant Wallace presented March and April formulary changes, explaining that the updates favored lower-cost generics, re-tiered some drugs, left several new-to-market drugs uncovered pending more evidence, and added quantity limits in some cases. The committee approved those formulary recommendations. The subcommittee also approved a cell and gene therapy policy that would exclude automatic coverage of those therapies and route them through prior authorization and review, with members noting the process should not delay urgent cases and that appeals remain available. Members then discussed a UAMS professional consultant services contract amendment for pharmacy benefit consulting. The discussion focused on confusion over the dollar amount and scope, with Wallace clarifying that the committee was being asked to approve up to $2.596 million, including optional services related to coupon and rebate management that could be used later without returning for another approval. Several members raised concerns about matching the written contract to the approval amount and about the relationship to the current pharmacy benefit manager, but the committee ultimately approved the item with the understanding that any use of the optional services would return to the committee. The committee also reviewed, without objection, a Blue Cross/Blue Advantage third-party administrator contract, a CompSack employee assistance program contract, and approved proposed 2027 employee and public school health plan rates of 9.8% and 4.9% increases, respectively. Wallace also said the UnitedHealthcare rebid was in final negotiation and would return in August. On the property risk side, the committee reviewed permanent rules for the property insurance program, a contingency-fee subrogation contract with Denenberg-Tuffly, and extensions for Sedgwick Claims Management, Actuarial Advantage, and Stevens Capital Management. Members asked about claim-adjustment delays after a major winter storm, and Wallace said performance guarantees and communication requirements had been added, with claims still expected to vary by case. The committee also approved 2026-27 captive insurance program rates, which included no change to minimum deductibles, lower rates for K-12 and higher education, a higher rate for state agencies, and an overall 10% reduction. Wallace said the reductions reflected improved actuarial foundations, better claims management, and the program’s first-year performance. The meeting adjourned after approving the rate item.

Transcript Highlights:

• So that would be the unresolved nature of the formulary there.
• Happy to pause there for questions. formulary council to do so. Um that formulary council to do so.
• unresolved nature of the formulary unresolved nature of the formulary there.<00:58:00.319> Um
• their formulary. their formulary. it<00:59:13.280> is<00:59:13.520> no<00:59:13.760
• hen house the way they're formulary hen house the way they're formulary advisory<00:59:46.880>

Keywords: 928, house, all

Summary: The committee opened by approving the September 5, 2025 minutes, with one member asking that future minutes use honorifics such as Mr. or Ms. The agenda was then adjusted so Police Standards and Training could present first. Director John Skipa reported on the 2019 performance audit, saying 12 of 16 findings were fully resolved and the remaining items were substantially or partially resolved. He highlighted work on a job task analysis to update curriculum and develop a more realistic physical aptitude test, including possible replacement of the long-used Cooper test and a shift away from mandatory baton training toward electronic weapons training. He said stakeholder work groups would meet in October and November, with a goal of completing the work by the first quarter of 2026. On the strategic planning and performance measurement finding, Skipa said the agency had relied on the 2019 audit and the LEAC report as guides while also implementing a digital records system. He acknowledged that a formal forward-looking strategic plan with the council had not yet been completed, but said he and the council chair wanted to do so, possibly through a retreat-style planning session. Members asked how many LEAC recommendations had been fully implemented; Skipa said he did not know the exact number but believed nearly all of the 22 items assigned to his agency were complete. On the administrative rules finding, he said a part-time former director had been brought back to help revise outdated rules, the council subcommittee had finished its work, and proposed changes would be sent to the full council, then to stakeholders and the public, with a public hearing expected and implementation targeted for 2026. For the Corrections Advisory Committee finding, Skipa said the committee had been reconvened in 2020 and 2021 but had limited usefulness because the statutorily named members were mostly high-level administrators rather than line supervisors or newer corrections staff. He said some positions later went unfilled because of budget and staffing issues, and the committee had not been called back, but he was open to either informal adjustments or possible legislative changes to make the committee more useful. Committee members suggested that the statute may need to be amended to allow more appropriate designees or supervisors to participate. After Police Standards and Training concluded, the committee moved on to the Office of Professional Licensure and Certification, where the executive director said he would focus on the partially resolved items in the dental examiner audit and the National Path audit, noting that many changes were tied to recent statutory revisions.

Transcript Highlights:

• This will be the March and April Employee Benefits Division formulary recommendations.
• lower-cost options that we're restructuring to make sure that we have the lower-cost preferred on our formulary
• We do have alternatives that we are covering already on the formulary.
• So I will say when we have switched to a new pharmacy benefit manager, yes, there was an overall formulary
• The formulary is an active, living, breathing document.

Keywords: 1204, all

Summary: The State Insurance Programs Oversight Subcommittee met on June 17 and reviewed a series of Employee Benefits Division and Office of Property Risk items. Grant Wallace presented March and April formulary changes, including moving to lower-cost generic and preferred drugs, leaving several new-to-market drugs not covered, and adjusting migraine and diabetes medications; the committee approved those recommendations. The subcommittee also approved a cell and gene therapy policy that excludes automatic coverage for those therapies so they can undergo prior authorization and review, with members emphasizing that the policy was intended to create review, not an absolute denial, and that expedited appeals would remain available. Members spent significant time discussing the UAMS pharmacy benefit consultant amendment. Wallace explained that the contract included both basic services and optional services related to coupon and rebate management and prior authorization support, but the written materials created confusion over the dollar amount. After questions about whether the committee was approving a higher amount than the base contract and whether the optional services duplicated work already being done by Navitus, the committee agreed to review the item with a contingency that any use of the optional services would return to the committee for approval. The committee also reviewed and approved the U.S. Able Mutual/Blue Advantage third-party administrator contract, the CompSack employee assistance program contract, and the proposed 2027 employee and public employee rates, which call for a 9.8% increase for state employees and a 4.9% increase for public school employees. On the property risk side, the committee reviewed permanent rules for the property insurance program, a contingency-fee subrogation contract with Denenberg-Tuffley, and renewals for Sedgwick claims management, Actuarial Advantage, and Stevens Capital Management. Wallace said Sedgwick had faced delays after a major winter storm and other weather events, but performance guarantees and communication expectations were being added; members discussed whether a shorter renewal term would be preferable, but the item was reviewed. The committee also approved the 2026-27 captive insurance program rates, which Wallace said would lower the overall rate by 10% while keeping minimum deductibles unchanged. He noted the program had stabilized after a difficult first year and that the rate structure was now based on a more transparent actuarial foundation. The meeting ended with an update that the UnitedHealthcare rebid was nearing completion and would return in August, and the committee adjourned after approving the remaining items.

Transcript Highlights:

• So what the amendments will do is that 60 days prior to the medication being placed on the formulary,
• And not just the basic generic information that we get right now when something's coming on a formulary
• The providers will always be notified of a new change to the formulary.
• We know what formularies our patients are on. We know what drugs are going to be covered.
• We're used to going through a lot of the paperwork and we understand what's on formulary.

Keywords: 988, house, all

Transcript Highlights:

• Health will provide more detail in the required notice to patients and providers when there is a formulary
• So what the amendments will do is that 60 days prior to the medication being placed on the formulary,
• And not just the basic generic information that we get right now when something’s coming on a formulary
• The providers will always be notified of a new change to the formulary.
• We know what formularies our patients are on. We know what drugs are going to be covered.

Summary: The committee heard several bills, beginning with SB 1312 by Senator Richardson on abandoned endowed-care cemeteries. Richardson described vandalism, theft, and neglect at abandoned cemeteries and said the bill would define abandonment, create a process for local governments to declare a cemetery abandoned, and allow the Bureau to act as conservator of endowment funds. Support came from Marin County, while county and special district groups opposed or had concerns, arguing the bill could shift burdens to local governments or public cemetery districts without enough safeguards. Members expressed general support but noted the need for further work; the bill was discussed but no final vote was taken in the excerpt. The committee then took up SB 758 by Senator Umberg, which would restrict retail sales of nitrous oxide to curb misuse. Supporters, including the League of California Cities, narcotic officers, counties, pediatricians, and other local governments and health groups, said easy access at smoke shops and convenience stores has fueled recreational abuse and health harms. There was no opposition testimony, and members voiced strong support for a statewide approach over city-by-city bans. The bill was well received, with the author closing in support. Dr. Weber-Pierson presented SB 1094, a health care affordability bill on biosimilars and biologic substitution. The bill would allow pharmacists to substitute biosimilars under certain conditions, require advance notice to providers and patients, and add reporting on savings; the author said amendments would strengthen provider notice and preserve the ability to mark prescriptions “do not substitute.” Supporters from health plans, insurers, pharmacies, labor, business, and some provider groups argued the bill would lower costs and expand access. Opponents, including dermatology and rheumatology groups and biotech interests, warned about non-medical switching, prior authorization delays, and patient harm. After extensive discussion, the committee voted 13-0 to pass SB 1094 to the Committee on Health. The committee also passed SB 849 by Dr. Weber-Pierson, which would bar reinstatement of physicians who surrendered their licenses while a sexual misconduct accusation was pending. The Medical Board and California Medical Association were generally supportive or neutral, and members praised the bill’s patient-protection focus. SB 993 by Senator Ochoa Bogh, which limits routine disclosure of identifying information for mental health professionals in correctional and psychiatric settings while preserving complaint processes, also passed unanimously to Appropriations. SB 1002 by Senator Niello, extending the David Hall Act to allow certain patients in remission to continue telehealth care with out-of-state specialists, drew strong patient support but opposition from the Medical Board and CMA over licensure and oversight concerns; the committee voted it out on a split roll with some members not voting. Finally, SB 1263 by Senator McGuire, aimed at protecting wildfire survivors and workers by requiring licensed, trained contractors for post-disaster residential debris removal, received support from labor and the Contractors State License Board, with contractors raising a narrower amendment concern about scope.

Transcript Highlights:

• Healthcare Common Procedure Coding System (HCPCS), the Current Procedural Terminology (CPT), and Formulary
• And formulary is a list of preferred prescription medicines covered by an insurance plan and sorts drugs
• The CCS, CPT, and formulary get updated annually, although according to some clinicians and billing and
• So this means, for example, that after a formulary update, suddenly a patient that was on a certain type
• This person said, "Clinical decision-making is driven by insurance formulary, not individualized patient

Transcript Highlights:

• This will be the March and April Employee Benefits Division formulary recommendations.
• options that we're just restructuring to make sure that we have the lower-cost preferred on our formulary
• We do have alternatives that we are covering already on the formulary.
• So I will say when we have switched to a new pharmacy benefit manager, yes, there was an overall formulary
• The formulary is an active, living, breathing document.

Summary: The State Insurance Programs Oversight Subcommittee met on June 17 and reviewed a series of Employee Benefits Division and Office of Property Risk items. The committee approved formulary changes for March and April that favored lower-cost generics, removed some new-to-market drugs from coverage pending more evidence, and made maintenance changes to migraine and diabetes medications. Members also approved a cell and gene therapy policy that would route those therapies through prior authorization rather than automatic coverage; officials said the process should not delay urgent cases and that no current members would be affected. The committee then reviewed a UAMS pharmacy benefit consultant contract amendment, but after extended discussion about the written scope and dollar amounts, the motion was approved with the understanding that any use of optional services would return to the committee for further review. The committee also reviewed the U.S. Able Mutual/Blue Advantage third-party administration contract and the CompSack employee assistance program contract, which officials said would reduce per-member costs and add services. The subcommittee approved proposed 2027 rates for state employees and public employees, with a 9.8% increase for state employees and a 4.9% increase for public school employees. Officials also reported that the UnitedHealthcare rebid was in its final negotiation stage and would return in August, with medical and pharmacy coverage split as previously recommended. In response to questions, the director said the division was considering broader preventive-care offerings, including weight-loss drug coverage, but would proceed cautiously and with strong utilization controls and holistic support if such a program were adopted. On the property risk side, the committee reviewed permanent rules making prior temporary rules permanent, a contingency-fee subrogation contract, and renewals for claims management, actuarial services, and investment management. Members raised concerns about Sedgwick’s claim-adjustment timeliness and communication with school districts after severe weather events; officials said performance guarantees and communication expectations had been strengthened, but the renewal was kept at three years for continuity. Finally, the committee approved 2026-27 captive insurance program rates, which included no change to minimum deductibles, a 10% overall rate reduction, and bucketed rate changes by entity type. Officials said the captive program was working as intended, with improved actuarial support and claims experience, and the meeting adjourned after the approvals.

Transcript Highlights:

• insulin, is on the drug formulary because the PBMs make more money from it.
• Sometimes on drug formularies, for example, lower-cost insulin, or sometimes only higher-cost insulin
• is on the drug formulary because the PBMs make more money from it.
• I mean, PBMs get hired to negotiate the lowest net price on the formulary as possible, and those rebates
• I'll add to that that when drugs go generic, PBMs often keep the brand name on their formulary for months

Summary: The committee heard several health-related measures. SB 27 by Senator Umberg would revise and expand California’s CARE Court by limiting the expansion to people with bipolar I disorder with psychotic features, clarifying the definition of “clinically stabilized,” and narrowing the role of nurse practitioners and physician assistants. Supporters, including behavioral health officials and family members, said the bill would reduce dismissals and better serve people with severe illness; opponents warned the expansion would strain county staffing and housing resources and could undermine voluntary engagement. The bill passed on a do pass motion to the Committee on Public Safety. SB 503 by Senator Weber Pierson would require AI tools used in health care facilities to be identified, monitored, and mitigated for bias when used in clinical decision-making or resource allocation. The author and supporters from Kaiser Permanente and the California Medical Association said the bill would help prevent discriminatory outcomes and improve trust and safety. The committee discussed the need to clarify developer and deployer responsibilities, and the bill passed as amended to Privacy and Consumer Protection. SB 68 by Senator Menjivar would require restaurants to provide written allergen information for the top nine food allergens, with tiered flexibility for smaller establishments. The bill was supported by patients, families, nurses, and allergy organizations, who described severe reactions and the difficulty of relying on verbal disclosures alone. The California Restaurant Association opposed unless amended, seeking broader use of the national model food code and additional liability language. The bill passed as amended to Appropriations. The committee also heard SB 403 by Senator Blakespear, which would remove the sunset from the End of Life Option Act; supporters described the law as a compassionate, well-functioning option for terminally ill patients, while faith-based groups opposed it. The bill passed to Judiciary. Later, SB 41 by Senator Wiener was introduced to rein in pharmacy benefit manager practices that steer patients to mail-order pharmacies and reimburse community pharmacies below cost; community pharmacists and several health organizations testified in support, describing pharmacy closures and patient access problems.

Transcript Highlights:

• Now, I'd like to further discuss the formulary changes that went into effect on March 1st, 2026.
• formulary alternatives.
• formulary alternatives.
• And it's simply just not as easy as it sounds to change formularies.
• They're adjusting formularies. They're restricting insurance premium assistance.

Summary: The Senate convened with a quorum, opened with prayer and the Pledge of Allegiance, and recognized several guests, including a state champion Crossroads Academy girls basketball team and a Florida State University student intern. The chamber then turned to executive appointment confirmations reported by the Committee on Ethics and Elections and other reference committees under Rule 12.7, with Chair Don Gates explaining that the committee had reviewed the qualifications and suitability of the nominees and held public hearings where required. Members debated several confirmations at length. The report containing 186 appointments was adopted 31-0 after Senator Polsky explained her no votes on three nominees, citing concerns about past comments and ideological views. The Senate then confirmed Jeffrey Aaron to the Public Employee Relations Commission by a 26-10 vote after sharp debate over his role as counsel to the Hope Florida Foundation and allegations tied to the diversion of Medicaid settlement funds; supporters argued he was a competent lawyer and no formal action had been taken against him. Chavon Harris was confirmed as Secretary of the Agency for Health Care Administration by a 32-5 vote, with supporters praising her work on Medicaid funding and opponents criticizing her prior leadership at DCF and the Hope Florida-related issues. Taylor Hatch was confirmed as Secretary of the Department of Children and Families by a 33-4 vote, despite concerns raised about SNAP/EBT compliance, child welfare practices, audits, and DCF’s handling of Hope Florida; supporters emphasized her commitment to reform and the difficulty of the agency’s mission. After a brief recess, the Senate held a lengthy recognition of outgoing President Kathleen Passidomo. Senators from both parties offered personal tributes focused on her leadership, toughness, humor, mentorship, and support for colleagues, especially women in the chamber. Several speakers also referenced her handling of difficult bills, her post-presidency service as Rules Chair, and her resilience after personal loss. No further legislative action was taken during the recognition segment.

Transcript Highlights:

• And on the formulary, Miss Grom, how would it compare from a state cost perspective on the market?
• I will say that current law requires DHS to have and maintain a drug formulary committee, which works
• And so our drug formulary committee would consider that information from the FDA.
• have and and maintain a drug formulary have and and maintain a drug formulary committee<00:36:23.599
• Um, and so our drug formulary based on.

Bills: HF3521, HF1807, HF1270, HF2070, HF3136

Keywords: hospital moratorium, hospital construction, bed capacity, hospital expansion, health care facilities, hospital licensing, safety-net hospital, level I trauma center, Ramsey County, Minnesota health law, hospital beds, new hospital exception, certificate of need, inpatient capacity, emergency care, trauma services, health system regulation, state moratorium, hospital modernization, health infrastructure

Transcript Highlights:

• state, and actually everybody would get a formulary, a workers' comp-specific formulary that could be
• And Nevada’s formulary isn’t costing them a dime because we give the formulary.
• “Not the formulary.” “Okay.
• There was also some talk about the formulary with Texas and ODG.
• were not covered under the Texas formulary.

Keywords: 965, house, all

Summary: The committee first disposed of several measures without debate, including deferrals of House Bill 460, House Bill 561, Senate Bill 322, and another deferred Senate measure, before taking up House Bill 819 by Chairman Cruz. HB 819 would replace Louisiana’s current workers’ compensation medical treatment schedule with ODG by MCG, a private evidence-based guideline system used in other states. Cruz and Troy Prevo argued ODG is more comprehensive, updated more frequently, and could reduce claim duration, medical costs, and premium rates; Dr. Jason Picard said Louisiana already uses ODG as a secondary reference for gaps in the state schedule and that the bill would not change appeals or variance procedures. Opponents, including injured-worker advocates Joseph Jola St. and Robin Crumholt, argued Louisiana’s current guidelines are working, that ODG is more cost-cutting and insurer-driven, and that the bill could increase denials and delay care. Members discussed amendments to add a two-year sunset, allow tacit approval when treatment follows the schedule, require payment within 30 days, and raise the carrier’s burden to challenge care; the committee adopted the amendments and then reported HB 819 favorably by a 7-6 vote. The committee then began Senate Bill 409 by Senator Myers, the Louisiana Living Donor Leave Protection Act. The bill would provide paid leave protections for living organ donors, set eligibility and verification procedures, and prohibit forfeiture of leave in certain circumstances for private employers. Myers said the measure is intended to remove job and paycheck barriers for people willing to donate organs and to support better transplant outcomes. Technical amendments were adopted at the start of the presentation, and the bill was introduced for further discussion.

Transcript Highlights:

• And if the manufacturer doesn't pay, then that keeps them off the formulary or the list of covered drugs
• and access, ...have enormous control over formulary and access and tiering, and then the next six, like
• and access, represent 80% of the market have enormous control over formulary and access in tiering and
• and reimbursement throughout the system, but it doesn't take away any of the PBM's functions in formulary
• make this language clearer, so we are not being affected by a PBM putting something on or off a formulary

Keywords: 995, all

Summary: The Joint Committee on Health Care Financing held a public hearing on a broad set of health care bills focused on cost, market oversight, pharmaceutical access, transparency, hospital closures, and pharmacy access. Chairs John Lawn and Cindy Friedman opened by emphasizing recent health care reforms and the need for further action on the drug supply chain, PBMs, private equity, and affordability. The committee heard testimony on several measures, including a Betsy Lehman Center bill to make technical changes and create a permanent trust account for federal and private funding, and bills on hospital profits and fairness, hospital closures and health planning, pharmacy deserts, and health care market oversight and pharmaceutical access. No votes were taken during the hearing. On the hospital profits bill, physicians and labor advocates strongly supported capping hospital CEO compensation at 50 times the lowest-paid worker, requiring greater financial transparency, and directing penalties from high-margin public hospitals into a Medicaid reimbursement fund. Testifiers argued that executive pay is excessive while frontline staff and safety-net services are under strain. Committee members raised concerns about unintended consequences, including whether hospitals might shift workers to contract status or lose executive talent, and whether the bill would actually direct money to the safety net. Supporters responded that the measure is one piece of a larger effort and that the bill’s Medicaid reimbursement provisions would help underserved hospitals. Testimony on market oversight and pharmaceutical access centered on rising health care and drug costs, PBM practices, and the proposal to give the Health Policy Commission authority to set upper payment limits for certain drugs. Consumer advocates, disability advocates, an independent pharmacist, the Attorney General’s office, and others supported stronger oversight, citing premium increases, affordability problems, and the impact of high drug prices on patients and community pharmacies. Pharma and some industry witnesses opposed parts of the bill, warning that upper payment limits could disrupt access, create legal issues, and fail to address the broader supply chain. The committee also heard support for stronger hospital closure notice and public hearing requirements, and for a pharmacy deserts bill aimed at identifying and addressing closures like the one in Roxbury that affected thousands of patients.

Transcript Highlights:

• It provides the board must create a negative formulary of medications to ensure that it is clear which
• It provides the board must create a negative formulary of medications to ensure that it is clear which
• And so one of the things that, when I talked about the formulary, it will say exactly what an optometrist
• And so one of the things that, when I talked about the formulary, it will say exactly what an optometrist
• And so one of the things that when I talked about the formulary, it will say exactly what an optometrist

Summary: The subcommittee met with a quorum present and took up five health-related bills. HB 1089, which would add Duchenne muscular dystrophy to Florida’s newborn screening panel, was presented as a way to enable earlier diagnosis and treatment; a pediatric neurologist from Nemours testified in support, noting existing FDA-approved therapies and ongoing clinical trials. After supportive debate, the bill passed 17-0 and was reported favorably. HB 1083 would standardize patient access to medical records by setting deadlines for providers to produce or allow inspection of records and requiring electronic delivery when available. Supporters said it would reduce delays in care and costs, while two industry groups appeared in opposition. Members from both parties spoke in favor, and the bill passed 17-0 and was reported favorably. HB 1297, which aligns Florida’s electronic prescribing rules more closely with federal law and removes some state exceptions, drew opposition from physicians who argued paper prescriptions are still needed for emergencies, shortages, and price shopping. The sponsor said the bill’s goals were patient safety, fraud prevention, and efficiency; despite concerns, it passed 18-0 and was reported favorably. The committee then considered PCS for HB 1421, the Emily Adkins Family Protection Act, which would create a statewide blood clot and pulmonary embolism registry, require hospital reporting and risk-assessment policies, and expand training requirements in hospitals, nursing homes, and assisted living facilities. The bill was presented with emotional testimony from Emily Adkins’ parents, who urged support and co-sponsorship in her memory. Members from both parties praised the family’s advocacy, and the PCS passed 18-0 and was reported favorably. Finally, HB 449 on optometry would expand optometrists’ authority to prescribe certain medications and perform specified laser and non-laser eye procedures after certification. The bill and amendment drew strong opposition from ophthalmologists and their association, who raised patient-safety, training, and delegation concerns, while optometrists argued the bill would improve access, especially in rural areas and counties without ophthalmologists. The amendment was adopted, and the bill as amended passed on a recorded vote and was reported favorably.

Transcript Highlights:

• Do you know that when the PBM sets the... sets the formulary, they set the price of what they paid the
• The formulary created by Dr. Paul Hubbard and... The formulary that Dr.
• They get a rebate to put that name brand drug on their formulary, and then even if... on their formulary
• economical generic equivalent available in the market, you can't get it because it's not on your formulary

Keywords: 923, senate, all

Transcript Highlights:

• For example, there's a formulary requirement change that will allow people to access medications that
• <01:14:54.000> um<01:14:54.159> change a formulary uh requirement um change a formulary
• Line 205 is the governor's recommendation relating to the drug formulary review committee.
• <01:51:22.880> review to the drug uh formulary review to the drug uh formulary review committee
• um health insurance plan formulary um health insurance plan formularies. formularies. formularies.

Keywords: 1187, senate, all

Transcript Highlights:

• Line 206, our savings tracked on the spreadsheet related to the drug formulary review committee sunset
• Line 364 tracks the Senate position on health insurance plan formulary requirements.
• insurance plan formulary insurance plan formulary requirements.<00:09:16.240> Lines<00:09
• Another key provision, the formulary freeze, will allow Minnesotans to keep their needed prescriptions
• Um, another key provision,<00:57:50.240> uh,<00:57:50.319> the<00:57:50.480> formulary

Keywords: 1187, senate, all